Latest News about Health Care
Recent news which mentions Health Care
From Benzinga
'Most Widely Hated' Bull Market Reaches 2-Year Milestone: Top 20 S&P 500 Stocks Driving The Rally
October 14, 2024
From Benzinga
Muay Thai Legend 'Huracán' Talks Business, Wellness & Cannabis As His Boxing Brand Expands To US
October 14, 2024
Tickers
NEWS
From Benzinga
Johnson & Johnson Preps For Q3 Earnings As MedTech Expands, But Stock Sends Mixed Signals
October 14, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year
October 14, 2024
From Benzinga
FDA Approves Pfizer's Second Hemophilia Drug With Six Months
October 14, 2024
From Benzinga
Fact-Check DeSantis: Why Florida's Weed Legalization Does Not Mean Smoking In Schools
October 12, 2024
From Benzinga
Melinda French Gates Pledges $250M To Address Women's Biggest Needs: 'Need To Do A Better Job'
October 11, 2024
Tickers
NEWS
From Benzinga
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
October 11, 2024
From Benzinga
ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential
October 11, 2024
From Benzinga
Teva Pays $450M To Resolve Alleged Kickback, Price-Fixing Schemes
October 11, 2024
From Benzinga
GSK Settles Majority Of Zantac Lawsuits, But Pipeline Doubts Remain
October 11, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free